FDA Pulls Back on Stricter Rules for Tanning Beds and Sunlamps
Published Date: 3/16/2026
Proposed Rule
Summary
The FDA has decided to stop moving forward with a 2015 plan that would have put stricter rules on selling and using sunlamp products like tanning beds. This means businesses and users won’t face new restrictions or extra costs from this rule. The withdrawal is official as of March 16, 2026, so things stay as they are for now.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Existing 2014 Sunlamp Rules Still Apply
Sunlamp products were reclassified to class II in a June 2, 2014 order that became effective September 2, 2014, making them subject to 510(k) premarket notification and special controls. Those special controls include performance testing, labeling requirements, and a warning that sunlamp products should not be used on persons under age 18.
Proposed Sunlamp Restrictions Withdrawn
The FDA withdrew its December 22, 2015 proposed rule on restricting sale, distribution, and use of sunlamp products. As of March 16, 2026, businesses and users will not face the new restrictions or extra costs that would have come from that proposed rule, so current practices remain in place for now.
Performance Standard Amendments Unaffected
FDA said its proposed amendments to the sunlamp products and UV lamps performance standard at 21 CFR 1040.20 are not affected by this withdrawal. That means the separate proposed technical and labeling updates at 21 CFR 1040.20 remain a separate action.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
Previous / Next Documents
Previous: 2026-05097 — Amendment of Class D and Class E Airspace and Revoke Class E Airspace; Fort Knox, KY
The FAA is updating the airspace rules around Fort Knox, KY, because an old navigation beacon was turned off. This means changing some flight zones and removing others to keep things safe and clear for pilots. If you fly or work near Fort Knox, these changes could affect you starting soon, and the FAA wants your feedback by April 30, 2026.
Next: 2026-05105 — Prediction Markets
The Commodity Futures Trading Commission (CFTC) is asking for your thoughts on prediction markets—places where people bet on future events. They want to know what rules should apply, which bets might be off-limits, and how these markets impact everyone. If you have ideas, send them by April 30, 2026, because this could lead to new rules that affect traders and the public.